Publications:

Plasma circulating tumor DNA assessment reveals KMT2D as a potential poor prognostic factor in extranodal NK/T-cell lymphoma.

Biomarker Research

Li, Qiong Q; Zhang, Wei W; Li, Jiali J; Xiong, Jingkang J; Liu, Jia J; Chen, Ting T; Wen, Qin Q; Zeng, Yunjing Y; Gao, Li L; Gao, Lei L; Zhang, Cheng C; Kong, Peiyan P; Peng, Xiangui X; Liu, Yao Y; Zhang, Xi X; Rao, Jun J

Publication Date: 2020

Variant appearance in text: KMT2D: V160L

PubMed Link: 32695399

Variant Present in the following documents:

• Main text
• 40364_2020_Article_205.pdf

View BVdb publication page